Polyserositis secondary to COVID-19: the diagnostic dilemma

9Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

COVID-19 is a novel disease often presenting with a cough, fever or a change in smell or taste. Recently, it has been recognised that COVID-19 may result in multisystemic issues and thus cause atypical symptoms, which can cause diagnostic delay, uncertainty and inaccuracy. A 60-year-old woman presented to the hospital with a 2-day history of mid-thoracic discomfort, intermittent rigours, fevers and general malaise, a few weeks after likely COVID-19 infection. She was admitted and treated for community-acquired pneumonia. However, her symptoms recurred despite multiple courses of antibiotics, which prompted further workup. A combination of a pleural and pericardial effusion was identified, leading to a diagnosis of polyserositis, and a COVID-19 antibody test came back positive. Colchicine was effective at resolving her symptoms, leading to further conviction of a probable postviral polyserositis.

Cite

CITATION STYLE

APA

Harris, E., Shanghavi, S., & Viner, T. (2021). Polyserositis secondary to COVID-19: the diagnostic dilemma. BMJ Case Reports, 14(9). https://doi.org/10.1136/bcr-2021-243880

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free